Showing results (1-10 of 34) with videos related to
Sort By:
Pageof 4
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 10, 2001
Potential risks and prevention, Part 3: Drug-induced threats to lifeK Marcellino, W N KellyFaculty Reviews|April 5, 2021
Recent advances in prognostication and treatment of polycythemia veraBridget K Marcellino, Ronald HoffmanClinical Lymphoma, Myeloma & Leukemia|March 23, 2020
The Myelodepletive Phenotype in Myelofibrosis: Clinical Relevance and Therapeutic ImplicationBridget K Marcellino, Srdan Verstovsek, John MascarenhasClinical Advances in Hematology & Oncology : H&O|August 19, 2021
Alternatives to intensive treatment in patients with AMLGracie Himmelstein, John Mascarenhas, Bridget K MarcellinoClinical Advances in Hematology & Oncology : H&O|July 8, 2022
JAK inhibitors in the treatment of myelofibrosisHannah Levavi, Ronald Hoffman, Bridget K MarcellinoThe Mount Sinai Journal of Medicine, New York|January 27, 2010
Cell "self-eating" (autophagy) mechanism in Alzheimer's diseaseSarah F Funderburk, Bridget K Marcellino, Zhenyu YueCurrent Neurobiology|March 2, 2019
Dietary Restriction and Glycolytic Inhibition Reduce Proteotoxicity and Extend Lifespan via NHR-49Bridget K Marcellino, Nydia Ekasumara, Charles V MobbsBlood Reviews|July 30, 2025
Target practice: Opportunities for therapeutic intervention in CHIP and CCUSAyman Mohammad, John Mascarenhas, Bridget K Marcellino, et al.Leukemia Research|July 6, 2026
Multispecialty referral patterns to a clonal hematopoiesis clinic: Who, what, and why?Ayman Mohammad, Sushruta Iruvanti, Bridget K Marcellino, et al.Critical Reviews in Oncology/Hematology|October 25, 2023
Clonal hematopoiesis and inflammation: A review of mechanisms and clinical implicationsDaniel I Nathan, Max Dougherty, Manasa Bhatta, et al.Pageof 4